Literature DB >> 27593085

Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.

Seo Ki Kim1, Inhye Park1, Jung-Woo Woo2, Jun Ho Lee3, Jun-Ho Choe1, Jung-Han Kim1, Jee Soo Kim4.   

Abstract

BACKGROUND: Because there is a controversy regarding the management of papillary thyroid microcarcinoma, the purpose of this study was to compare lobectomy with total thyroidectomy as a primary operative treatment for papillary thyroid microcarcinoma. Loco-regional recurrence in the contralateral remnant lobe can be managed safely by completion thyroidectomy via the previous scar. However, reoperation for operation bed (thyroidectomy site) or regional lymph node (central or lateral) recurrence generally is associated with morbidity. Therefore, we analyzed overall loco-regional recurrence and loco-regional recurrence outside of the contralateral remnant lobe separately.
METHODS: We retrospectively reviewed 8,676 conventional patients with papillary thyroid microcarcinoma who underwent thyroidectomy.
RESULTS: Lobectomy was performed in 3,289 (37.9%) patients, and total thyroidectomy was performed in 5,387 (62.1%) patients. Total thyroidectomy significantly decreased the risk of overall loco-regional recurrence (adjusted hazard ratio 0.398, P < .001). However, total thyroidectomy did not significantly decrease the risk of loco-regional recurrence outside of the contralateral remnant lobe (adjusted hazard ratio 0.880, P = .640). Particularly in conventional papillary thyroid microcarcinoma patients with multifocality, total thyroidectomy significantly decreased the risk of overall loco-regional recurrence (adjusted hazard ratio 0.284, P = .002) and loco-regional recurrence outside of the contralateral remnant lobe (adjusted hazard ratio 0.342, P = .020).
CONCLUSION: Although lobectomy is associated with contralateral remnant lobe recurrence, lobectomy did not increase the risk of loco-regional recurrence outside of the contralateral remnant lobe in patients with papillary thyroid microcarcinoma, except in those with multifocality. Because recurrence in the contralateral remnant lobe can be managed safely by completion thyroidectomy, lobectomy may be a safe operative option for select patients with papillary thyroid microcarcinoma without multifocality.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27593085     DOI: 10.1016/j.surg.2016.07.037

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  24 in total

Review 1.  Surgical management of papillary thyroid carcinoma: an overview.

Authors:  Paolo Miccoli; Sohail Bakkar
Journal:  Updates Surg       Date:  2017-04-12

2.  Recurrence-free survival after total thyroidectomy and lobectomy in patients with papillary thyroid microcarcinoma.

Authors:  M van Gerwen; M Alsen; E Lee; C Sinclair; E Genden; E Taioli
Journal:  J Endocrinol Invest       Date:  2020-07-10       Impact factor: 4.256

Review 3.  [Surgery of papillary thyroid microcarcinoma].

Authors:  T Weber; S Peth; R Hummel
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

4.  [Current controversies in risk-adapted therapy in differentiated thyroid cancer: Is less (therapy) really more?]

Authors:  Amir Kurtaran; Brigitta Schmoll-Hauer; Christina Tugendsam
Journal:  Wien Med Wochenschr       Date:  2019-12-03

Review 5.  Total thyroidectomy versus thyroid lobectomy in the treatment of papillary carcinoma.

Authors:  Marco Raffaelli; Serena Elisa Tempera; Luca Sessa; Celestino Pio Lombardi; Carmela De Crea; Rocco Bellantone
Journal:  Gland Surg       Date:  2020-01

6.  Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study.

Authors:  Liu Yihao; Li Shuo; Xi Pu; Wang Zipeng; Sun Hanlin; Chang Qungang; Wang Yongfei; Yin Detao
Journal:  Int J Endocrinol       Date:  2022-06-28       Impact factor: 2.803

7.  Impact of prophylactic unilateral central neck dissection needed for patients with papillary thyroid microcarcinoma.

Authors:  Young Jae Ryu; Jung Han Yoon
Journal:  Gland Surg       Date:  2020-04

8.  Thyroid lobectomy in patients with differentiated thyroid cancer: an analysis of the clinical outcomes in a nationwide multicenter study.

Authors:  Juan J Díez; Victoria Alcázar; Pedro Iglesias; Ana Romero-Lluch; Julia Sastre; Begoña Pérez Corral; Carles Zafón; Juan Carlos Galofré; María José Pamplona
Journal:  Gland Surg       Date:  2021-02

9.  Modulating the extension of thyroidectomy in patients with papillary thyroid carcinoma pre-operatively eligible for lobectomy: reliability of ipsilateral central neck dissection.

Authors:  M Raffaelli; C De Crea; L Sessa; S E Tempera; G Fadda; A Pontecorvi; R Bellantone
Journal:  Endocrine       Date:  2020-08-20       Impact factor: 3.633

10.  Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma.

Authors:  Hengqiang Zhao; Le Cui
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.